ABSTRACT Lassa virus (LASV) is an Old World arenavirus responsible for hundreds of thousands of infections in West Africa every year. LASV entry into a variety of cell types is mediated by interactions with glycosyltransferase LARGE-modified O-linked glycans present on the ubiquitous receptor ␣-dystroglycan (␣DG). However, cells lacking ␣DG are permissive to LASV infection, suggesting that alternative receptors exist. Previous studies demonstrated that the phosphatidylserine (PtdSer)-binding receptors Axl and Tyro3 along with C-type lectin receptors mediate ␣DG-independent entry. Here, we demonstrate that another PtdSer receptor, TIM-1, mediates LASV glycoprotein (GP)-pseudotyped virion entry into ␣DG-knocked-out HEK 293T and wild-type (WT) Vero cells, which express ␣DG lacking appropriate glycosylation. To investigate the mechanism by which TIM-1 mediates enhancement of entry, we demonstrate that mutagenesis of the TIM-1 IgV domain PtdSer-binding pocket abrogated transduction. Furthermore, the human TIM-1 IgV domain-binding monoclonal antibody ARD5 blocked transduction of pseudovirions bearing LASV GP in a dose-dependent manner. Finally, as we showed previously for other viruses that use TIM-1 for entry, a chimeric TIM-1 protein that substitutes the proline-rich region (PRR) from murine leukemia virus envelope (Env) for the mucin-like domain served as a competent receptor. These studies provide evidence that, in the absence of a functional ␣DG, TIM-1 mediates the entry of LASV pseudoviral particles through interactions of virions with the IgV PtdSer-binding pocket of TIM-1.
T
he Old World arenavirus Lassa virus (LASV) causes hemorrhagic fever in humans, with estimates of 300,000 infections and 5,000 deaths each year in West Africa (Viral Hemorrhagic Fever Consortium). Unfortunately, no vaccine has been approved for human use. Arenaviruses contain four viral open reading frames in two ambisense RNA genomic segments (1) , one of which encodes the glycoprotein precursor (for a recent review, see reference 2). Cellular processing of this precursor protein generates the LASV glycoprotein (GP) complex that is found on the surface of arenavirions (3),
In this study, we found that that PtdSer receptor TIM-1 mediates the entry of either LCMV or vesicular stomatitis virus (VSV) pseudovirions bearing LASV GP but only when ␣DG either is not expressed or does not contain the necessary LARGE-dependent alterations of the O-linked glycans. This is consistent with findings that the high-affinity interactions of LASV GP and ␣DG prevail over lower-affinity PtdSer/PtdSer receptor interactions (49) . Furthermore, we found that the TAM receptor Axl was unable to serve as a receptor for LASV pseudovirions in HEK 293T and Vero cells, irrespective of the status of ␣DG in these cells.
RESULTS
LASV entry is TIM-1 dependent in Vero cells. Multiple lines of evidence indicate that ␣DG is not the only receptor available to Old World arenaviruses (45, (49) (50) (51) , although when appropriately glycosylated, ␣DG binds to LASV GP with high affinity and mediates Old World arenavirus entry (21, 22) . Although ␣DG is widely expressed throughout the body, some cell types do not glycosylate ␣DG in a way that is compatible with LASV GPC engagement and laminin binding (22) . As Vero cells are readily permissive to LASV but are not sensitive to laminin-mediated competition (22) , we assessed the ability of mAb IIH6 to bind to Vero cells. IIH6 has been previously shown to distinguish if ␣DG is glycosylated in a LASV GPC-compatible manner (22, 52) . Surface staining of cells with IIH6 demonstrated that suitably glycosylated ␣DG was detected on HEK 293T cells, but not Vero cells, yet both cell types had readily detectable dystroglycan on their surface (Fig. 1A) . These findings are consistent with previous studies proposing that ␣DG is not used by LASV for entry into Vero cells (22, 45) .
To determine if PtdSer receptors are involved in LASV entry into Vero cells, we assessed the surface expression of those PtdSer receptors most highly implicated in mediating enveloped virus entry (24, 28, (53) (54) (55) (Fig. 1B) . Because Vero cells are known to express abundant Axl at the cell surface (53) , others have proposed that Axl may mediate the entry of LASV into Vero cells (45) . We found that both TIM-1 and Axl were highly expressed on the surface of WT Vero cells, whereas other PtdSer receptors implicated in virus uptake (Tyro3, Mer, or TIM-4) had little or no expression.
To determine if Axl and/or TIM-1 serves as a receptor for LASV-VSV entry in Vero cells, we used CRISPR-Cas9 gene-editing technology to create both AXL and HAVCR1 (TIM-1) knockout (KO) Vero cell lines. We produced one Axl-KO cell line, two independently derived TIM-1-KO cell lines, TIM-KO 1 and TIM-KO 2 , and one Axl/TIM-1 double-KO (DKO) cell line. Successful KO was confirmed by cell surface staining with antibodies targeting the respective receptors (Fig. 1B) . Altered expression of DG, Mer, Tyro3, or TIM-4 was not observed in any of the KO cell lines, and all cell lines divided at similar rates (data not shown).
The impact of Axl or TIM-1 expression on LASV entry was assessed using two different types of virus particles. Pseudovirions generated from the Old World arenavirus LCMV and from the unrelated rhabdovirus VSV were pseudotyped with LASV GP and transduced into our Vero cell lines. Both pseudovirion systems expressed green fluorescent protein (GFP) as a reporter gene. Regardless of the viral particle bearing LASV GP, the loss of TIM-1 in Vero cells abrogated transduction, whereas the knockout of Axl expression had no effect ( Fig. 1C and E) . The DKO line that did not express either TIM-1 or Axl gave findings similar to those with TIM-1-KO lines alone, providing additional evidence that Axl is not being used by LASV-VSV for entry into Vero cells. The loss of TIM-1 expression in Vero cells did not affect the entry of all viruses, as the transduction of an adenoviral vector expressing enhanced GFP (Ad-eGFP) was not affected by the loss of TIM-1 (Fig. 1D ). To examine if the inability of Axl to support LASV-VSV transduction was due to low concentrations of Gas6 in our fetal calf serum (FCS), we transduced LASV-VSV into the TIM-1-KO lines in the presence of exogenous Gas6. Gas6 had no effect on levels of virus transduction (data not shown).
To confirm that the loss of TIM-1 expression was the cause of LASV transduction resistance in Vero cells, we performed a dose-dependent rescue experiment with adenovirus-delivered TIM-1 (Ad-TIM-1). While WT levels of TIM-1 expression in Ad-TIM- 1-transduced cells were not achieved in these studies, increasing levels of TIM-1 expression at the cell surface (Fig. 1F ) correlated with increasing LASV-VSV transduction (Fig. 1G ) in the Vero TIM-1-KO cell lines and the Axl/TIM-1-KO cell line.
LASV pseudovirion entry is ␣DG dependent in HEK 293T cells. We further evaluated the impact of PtdSer receptors on LASV pseudovirion transduction in HEK 293T cells. For these studies, we initially validated the importance of ␣DG for LASV-VSV entry. In these studies, we used CRISPR-Cas9 editing to knock out ␣DG expression in HEK 293T cells, generating two independent DG-KO cell lines, DG-KO 1 and DG-KO 2 . DG-KO lines were surface stained with anti-DG antibodies to confirm the loss of ␣DG expression at the cell surface ( Fig. 2A) , with WT HEK 293T cells being used as a positive control. Increasing concentrations of LASV-VSV or VSV pseudotyped with VSV G (VSV-VSV) were incubated with WT or ␣DG-KO lines. As expected, the loss of ␣DG had a profound impact on the transduction of pseudovirions bearing LASV GP (Fig. 2B) but not VSV-VSV (Fig. 2C) . To confirm that the loss of ␣DG was responsible for the reduction of LASV-VSV transduction in the KO lines, we performed dose-dependent rescue experiments with exogenous ␣DG. The endogenous expression level of ␣DG was high on WT HEK 293T cells ( Fig. 2A) , and transfection of an exogenous DAG1-expressing plasmid did not significantly increase either ␣DG expression or LASV-VSV transduction (data not shown). However, in the DG-KO lines, increasing levels of DG expression at the cell surface (Fig. 2D ) correlated with increasing permissivity to LASV-VSV transduction (Fig. 2E) , with statistically significant increases in LASV-VSV transduction in the DG-KO 1 line and a similar trend observed in the second KO line. These data support a role for ␣DG as a critical receptor for LASV-VSV entry in HEK 293T cells.
TIM-1 can serve as a receptor for LASV pseudovirions in the absence of ␣DG. We next sought to determine if PtdSer receptors mediate LASV pseudovirion entry into WT or DG-KO HEK 293T cells. Because HEK 293T cells do not endogenously express Axl or TIM-1 (Fig. 3A) , we evaluated whether the ectopic expression of either PtdSer receptor mediates LASV pseudovirion entry. With the transfection of increasing concentrations of a TIM-1-or Axl-expressing plasmid, dose-dependent increases in the levels of these PtdSer receptors were observed on the surface of transfected HEK 293T cells, regardless of the ␣DG status of the cells (Fig. 3B and D) . The presence of TIM-1 or Axl on WT HEK 293T cells did not increase levels of LASV-VSV transduction ( Fig. 3C and E), indicating that the expression of ␣DG rendered the addition of these PtdSer receptors superfluous for LASV-VSV entry. In contrast, TIM-1 expression strongly correlated with increasing LASV-VSV transduction in both DG-KO cell lines. These data are consistent with our findings in Vero cells and indicate that in the absence of DG expression, pseudovirions bearing LASV GP use TIM-1 as a receptor. In contrast to our findings with TIM-1, increasing Axl expression at the cell surface (Fig. 2D ) had no impact on LASV-VSV transduction in the DG-KO lines (Fig. 2E) , despite the ability of Axl expression in HEK 293T cells to enhance Zika virus entry, as others have shown (56, 57) , and to enhance Gas6-dependent cell migration (58) (Fig. 3F and G) .
Pseudovirions bearing LASV GP bind TIM-1 in a PtdSer-dependent manner. We and others have reported that PtdSer on a variety of enveloped viruses binds to a conserved PtdSer-binding pocket present in the amino-terminal IgV domain of TIM proteins (24, 28, 55, 60) . To assess whether the mechanism of TIM-1-mediated LASV pseudovirion transduction is similar to that of other enveloped viruses, we transduced LASV-VSV in TIM-1-expressing WT or DG-KO HEK 293T cells in the presence of antihuman TIM-1 monoclonal antibody (mAb) ARD5. ARD5 had no impact on LASV-VSV transduction in TIM-1-expressing WT HEK 293T cells, as LASV-VSV entry in these cells is ␣DG dependent, but it inhibited LASV-VSV transduction in TIM-1-expressing DG-KO HEK 293T cells in a dose-dependent manner (Fig. 4A ). ARD5 also inhibited LASV-LCMV transduction in both WT and Axl-KO Vero cells (Fig. 4B ). These data suggest that LASV pseudovirions interact with TIM-1 similarly to other enveloped viruses. To further explore if a PtdSer-dependent mechanism is used by pseudovirions bearing LASV GPC in DG-KO HEK 293T cells, we employed a previously characterized TIM-1 mutant, ND115DN, in which critical residues in the PtdSer-binding pocket (N114 and D115) were mutated (24) . As expected, increasing levels of ND115DN-TIM-1 Shown in panels A and B are means and standard errors of the means of data from three independent experiments. Shown in panels C to F are means and standard errors of the means of data from 3 to 5 independent experiments. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001.
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empty, Axl-expressing, or murine BST-2-expressing plasmids were plated on the insert of a transwell in serum-free medium. Medium containing 10% FCS with or without 0.5 g/ml of Gas6 was added to the bottom of the transwell apparatus. Cell migration to the bottom of the transwell filter was determined 24 h later. Data shown represent results of one of two studies that were performed in triplicate. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001; ns, not significant. expression at the cell surface (Fig. 4C) had no impact on the permissivity of WT or DG-KO HEK 293T cells to LASV-VSV transduction (Fig. 4D) . These data suggest that TIM-1-mediated LASV-VSV transduction requires a functional PtdSer-binding pocket and is likely PtdSer dependent.
Unlike TAM receptors, TIM receptors have an MLD that contains an abundance of O-linked glycans (61, 62) . Since ␣DG also has an MLD, and the interaction between LASV GPC and ␣DG is dependent on the O-linked glycans within the domain, we wanted to determine if the MLD in TIM-1 is also important for interactions with pseudovirions bearing LASV. To address this, we utilized a previously characterized mutant of TIM-1 in which the O-glycan-rich MLD was replaced with a proline-rich region (PRR) from the amphotropic 4070A murine leukemia virus envelope gene, PRR-TIM-1 (25) . To assess whether TIM-1-mediated LASV-VSV entry is MLD dependent, we performed a dose-dependent enhancement experiment with exogenous PRR-TIM-1. The level of PRR-TIM-1 expression at the cell surface was modest but increased with increasing amounts of the expression plasmid transfected (Fig. 4E) . PRR-TIM-1 expression had no impact on the permissivity of WT HEK 293T cells to LASV-VSV transduction; however, increasing levels of PRR-TIM-1 expression correlated with increasing LASV-VSV transduction in both DG-KO cell lines (Fig. 4F) . These data support PtdSer-dependent entry as the mechanism of TIM-1-mediated LASV-VSV transduction in DG-KO cells and confirm that specific residues within the TIM-1 MLD, despite similarity to that of ␣DG, are not critical for TIM-1-dependent entry.
DISCUSSION
␣DG is a ubiquitous cell surface receptor that, when appropriately glycosylated, interacts with LASV GP with high affinity (7) to allow the internalization of this Old World arenavirus into a broad range of cell types. Here, we show that endogenous TIM-1 expression in Vero cells or exogenous TIM-1 expression in HEK 293T cells mediates LASV pseudovirion transduction. However, TIM-1-dependent entry was evident only in the absence of functional ␣DG.
LASV pseudovirion entry is mediated by TIM-1 through interactions with the PtdSerbinding pocket within the TIM-1 IgV domain. Mutations in this pocket that are known to block binding and uptake of apoptotic bodies and other enveloped viruses (24, 28, 37) abrogated virus entry. Adding support to LASV pseudovirion PtdSer/TIM-1 interactions, we found that mAb ARD5, which binds to the TIM-1 IgV domain and is thought to conformationally alter the domain, inhibited transduction in a dose-dependent manner. Thus, consistent with previous Ebola virus (EBOV) and dengue virus studies investigating TIM-1-dependent entry (24, 28, 55, 60) , our findings provide evidence that TIM-1 enhances LASV pseudovirion entry through interactions with virion lipids rather than with LASV GP.
Our studies evaluated LASV entry using two different pseudovirions bearing LASV GP: LCMV (63) and VSV. Similar findings were observed with both virions, suggesting that sufficient quantities of PtdSer are present and available on these two different viral particles to allow TIM-1 interactions. As both of these viral particles bud from the plasma membrane, VSV and LCMV particles may contain similar lipid compositions.
LASV infects a variety of cell types, from epithelial and endothelial cells to macrophages and dendritic cells (49, 64, 65) , and TIM family members are surface receptors on a number of these cells. Thus, the TIM-1/LASV interaction may be relevant to in vivo LASV infection and pathogenesis, serving as a LASV receptor on cells lacking functional DG. We have shown previously that TIM-1 is expressed on mucosal epithelial cell populations (66) , and others have shown that TIM-1 is expressed on kidney tubule epithelial cells following ischemia (30) . The TIM family member TIM-4, which mediates enveloped virus infection in a manner similar to that of TIM-1 (55) , is robustly expressed on some tissue macrophages (27) . Future studies examining the role of TIM-4 in mediating Old World arenavirus infection in tissue culture and in vivo are needed.
Our studies support data from recent studies by Fedeli et al. (49), providing insights into why PtdSer receptor expression did not mediate LASV-VSV transduction in previ-ous studies, such as those performed in HEK 293T cells (47) . These cells have high levels of ␣DG on their surface, and only upon the knockout of ␣DG expression does the addition of exogenous TIM-1 expression affect LASV-VSV entry. Our findings indicate that the alternative entry route made available by TIM-1 expression is unable to compete for virion interactions in the presence of ␣DG.
By performing complementation studies in HEK 293T and Vero cells, we demonstrated that TIM-1 can serve as a receptor for pseudovirions bearing LASV GP (i) in the absence of ␣DG or (ii) in the presence of abundant yet unsuitably glycosylated ␣DG. Vero cells that have been shown to have aberrant ␣DG glycosylation are highly permissive to LASV-VSV, indicating the existence of an efficient route of LASV entry that is independent of the WT ␣DG O-linked glycans (22) . Beyond our expectations, knockout of TIM-1 in Vero cells rendered the cells refractory to LASV pseudovirions despite the continued abundance of another PtdSer receptor, Axl. While our data support a role for TIM-1 both in the absence of ␣DG in HEK 293T cells and as a primary route of entry in Vero cells, it is possible that additional surface receptors also mediate LASV-VSV entry into these cells and/or that TIM-1 acts simply as an attachment factor rather than a receptor that internalizes the virus into endosomes. Consistent with a potential role of other receptors for LASV uptake into Vero cells, others have determined that PtdSer binding in the TIM-1 IgV domain requires the incorporation of a divalent cation (30) , and while TIM-1-dependent EBOV-VSV transduction in Vero cells is sensitive to chelation with EGTA in a dose-dependent manner, LASV-VSV transduction has been shown to be unaffected by EGTA (24) . Additional studies are still needed to elucidate the role of and mechanism by which TIM-1, or other PtdSer receptors, mediates enveloped virus internalization.
While endogenous Axl expression on Vero cells or ectopic expression on transfected HEK 293T cells was robust, Axl did not mediate LASV pseudovirion transduction. Our findings with Axl are consistent with recent work demonstrating in several cell lines that the endogenous expression of Axl does not influence the entry of recombinant LCMV (rLCMV) encoding LASV GP (47) . However, it should be noted that the studies by Oppliger et al. were performed with ␣DG-expressing cells (47) , and the use of ␣DG by LASV likely abrogates the need for Axl. In contrast to our findings with Axl, Shimojima et al. showed that ectopic Axl expression in Jurkat T cells and endogenous Axl expression in HT1080 cells enhanced the entry of HIV or VSV pseudovirions bearing LASV GP (45) . Similar studies in HT-1080 cells also demonstrated that Axl could serve as a receptor for LASV (49) . LASV pseudovirions may utilize Axl-dependent uptake in a cell-specific manner. Such a conclusion is consistent with data from our previous study with EBOV-VSV pseudovirions demonstrating that some, but not all, cells that express robust levels of Axl at the cell surface support virus entry in an Axl-dependent manner (53) .
Since LASV GP interacts with the O-linked glycans present on the ␣DG mucin domain and both ␣DG and TIM-1 contain an extracellular MLD, it was possible that LASV GP was interacting with TIM-1 in a manner similar to that of ␣DG. To test this, we examined if the TIM-1 MLD was critical for LASV pseudovirion transduction. However, we found that TIM-1-dependent transduction was independent of the TIM-1 MLD, as the amphotropic MLV Env PRR could replace it. While previous studies of TIM-1 demonstrated that the MLD is required for enveloped virus uptake into cells, it is the length of the MLD stalk domain that is needed to enhance virus entry (25) rather than specific amino acids or O-linked glycans. The present study along with our previous work (25) provide evidence that the length of the PRR sequence is sufficient to substitute for the TIM-1 MLD and is consistent with an absence of LARGE-mediated glycan modifications associated with this mucin domain. This is not surprising, as O-mannosylation modifications of glycans that are found on ␣DG are thought to be relatively uncommon in mammals (67) , and more conventional O-linked glycans on ␣-DG do not play a role in arenavirus binding (21) .
We have previously proposed that the use of PtdSer receptors expands both the species and cellular tropism of some viruses (68), since specific receptor/viral GP interactions are not required for the interaction and subsequent virion internalization (24, 28) . Examples of enveloped viruses that utilize PtdSer receptors have been found to have GPs that interact with receptors within the endosomal compartment, such as EBOV or LASV (8, 69, 70) . Alternatively, arboviruses can utilize this GP-independent internalization mechanism, presumably because a fusion-ready conformation of their GP is generated during endosomal acidification, and do not appear to require GP/ receptor interactions to trigger fusion (reviewed in references 71 and 72). The use of PtdSer receptors is not limited to enveloped viruses, as it has been shown to mediate the entry of vesicle-bound hepatitis A virus (73) and poliovirus (74) . The breadth of viruses able to utilize this mechanism highlights the importance of this pathway in viral uptake. Continued work is needed to understand virus interactions with specific PtdSer receptors and why some of these receptors are preferentially targeted for use by viruses over others when both are expressed in the same cell.
MATERIALS AND METHODS
Cells and CRISPR-Cas9-mediated receptor knockout cell lines. Vero cells (ATCC CCL-81) and HEK 293T cells (ATCC CRL-3216) were maintained in Dulbecco's modified Eagle medium supplemented with 5 to 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin in a 37°C incubator with 5% CO 2 . The TIM-1 knockout Vero lines were generated and characterized as previously described (75) . WT and KO cells were evaluated for rates of cell division by measuring cellular ATP in an ATP Lite assay (PerkinElmer) over a 24-h period, the time frame used in our transduction studies. No significant differences were detected between the WT and KO cells in these assays.
To create ␣-dystroglycan knockout (KO) cell lines, CRISPR-Cas9 sequence targets (GX 20 GG) were identified on genomic DNA within exons of the gene of interest. These sequences were modified to include BbsI restriction sites on either end and were synthesized as oligonucleotides along with each reverse complement. Complementary sequences were annealed together and subsequently ligated into BbsI-digested pX330-U6-Chimeric_BB-CBh-hSpCas9 (pX330) (a kind gift from Kimberly Leslie, University of Iowa). All cloned constructs were confirmed by Sanger sequencing. KO cell lines were created using paired combinations of genomic sequence targets. For DG-KO 293T cell lines, two pairs of targets in DAG1 were cloned into pX330. For DG-KO 1 (also called D2), plasmids targeting GGA-AGG-AGG-CTT-TGC-CAT-CTT-GG (exon 2, coding strand) and GGA-CTC-ACA-GAG-CCA-CAC-CCT-GG (exon 2, coding strand) were used. For DG-KO 2 (also called F6), plasmids targeting GTG-AAC-CCT-CAG-AGG-CTG-TCA-GG (exonGP-deficient, GFP-expressing recombinant LCMV (rLCMV) (Armstrong strain) bearing LASV (Josiah) GPC was produced as previously described (63) . Briefly, Vero cell lines constitutively expressing LASV GP (63) were infected at a low multiplicity of infection (MOI of 0.01) with rLCMVΔGP/GFP. At 72 h postinfection (p.i.), LASV GP-pseudotyped rLCMVΔGP/GFP was collected from the supernatant, and titers were determined on LASV GP-expressing Vero cells.
Ad-hTIM-1 was created by cloning human TIM-1 (hTIM-1) downstream of the cytomegalovirus (CMV) promoter in the E1 cassette of the Ad shuttle pacAd5CMVmcspA (provided by the University of Iowa Viral Vector Core) with KpnI and NotI. Recombinant adenoviral vectors Ad-TIM-1, Ad-Empty, and Ad-eGFP were made by the University of Iowa Viral Vector Core as previously described (77) . Vector titers were ϳ10 10 PFU/ml.
Cell surface staining. The following polyclonal antibodies used in cell surface staining assays were obtained from R&D Systems: sheep anti-hDG (catalog number AF6868), goat anti-hAxl (catalog number AF154), goat anti-hTIM-1 (catalog number AF1750), goat anti-hMer (catalog number AF891), goat anti-hTIM-4 (catalog number AF2929), and goat anti-hTyro3 (catalog number AF859). Mannosylationdependent mouse anti-rabbit ␣DG monoclonal antibody IIH6 was developed by Kevin Campbell (University of Iowa) and obtained from the Developmental Studies Hybridoma Bank, created by the NICHD of the NIH and maintained at the University of Iowa Department of Biology, Iowa City, IA. IIH6 was used as the supernatant (29 g IgG/ml).
For surface staining experiments, cells lifted from plates with 5 mM EDTA in PBS were transferred into a 96-well round-bottom plate at ϳ200,000 cells per well. Cells were washed with 5% FBS in PBS three times prior to incubation with primary antibodies for 1 h on ice at concentrations specified in the respective figure legends. Primary-antibody-stained cells were washed three times and incubated with Cy5-conjugated donkey anti-goat (catalog number A21447; Life Technologies), donkey anti-sheep (catalog number 713-605-003; Jackson ImmunoResearch), or donkey anti-mouse (catalog number 715-175-150; Jackson ImmunoResearch) IgG secondary antibody at a 1:1,000 dilution for 15 min on ice. Secondary-antibody-stained cells were washed three times and subsequently analyzed via flow cytometry using a FACSCalibur instrument (Becton, Dickinson). Data were analyzed with single-cell analysis software (FlowJo).
Transductions. For all transductions, cells were plated at 50,000 cells per well in a 48-well format overnight, and virus stocks, as noted, were then applied to cells and assessed for GFP expression 18 to 24 h later by flow cytometry.
In LASV-VSV pseudovirion, VSV-VSV pseudovirion, or eGFP-encoding adenoviral vector transduction studies, increasing concentrations of virions were added to 15,000 cells in a 48-well tissue culture plate. In LASV-LCMV pseudovirion studies, a single dose (MOI of ϳ0.2) of the stock was used in 48-well transduction studies.
In studies where plasmids expressing surface receptors (␣DG, WT or mutant TIM-1, or Axl) were transfected prior to transduction experiments, cells were plated overnight in a 12-well format. Wells were transfected with 0, 0.25, 0.5, or 1 g of plasmid by using a polyethyleneimine (PEI)-based transfection protocol. Cells were split into two groups 24 h following transfection. Forty-eight hours following transfection, one group of the cells was transduced, whereas the other transfected cells were assessed for receptor surface expression by flow cytometry. For these transduction experiments, equivalent amounts of pseudovirions (MOI of ϳ0.15) were added, resulting in ϳ15 to 20% transduction of WT HEK 293T cells. MOIs of stocks used in these studies were determined by transducing 2-fold serial dilutions of pseudovirus onto WT HEK 293T cells for 24 h and assessing GFP expression by flow cytometry. An MOI in the linear range of the curve was selected for use in these studies. This value was selected because this level of transduction is in the linear range of the transduction curve. The same quantity of pseudovirions applied to untransfected receptor knockout lines gave dramatically lower levels of transduction.
For assessing the ability of anti-human TIM-1 monoclonal antibody ARD5 to inhibit LASV-VSV transduction, WT or ␣DG CRISPR-Cas9-knocked-out HEK 293T cells were transfected with a human TIM-1-expressing plasmid. ARD5 was added to wells at the concentrations noted above for 1 h prior to LASV-VSV transduction. Equivalent amounts of LASV-VSV pseudovirions were added to the treated or untreated cells. Transduction levels were determined 24 h later by assessing the GFP positivity of cells by flow cytometry. Similar protocols were used for studies that were performed with LASV-LCMV in WT or Axl-KO Vero cells.
For transduction experiments with WT and CRISPR-Cas9-knocked-out Vero cells, cells were plated overnight in a 12-well format prior to transduction with an empty adenovirus (Ad-Empty) or an adenovirus expressing TIM-1 (Ad-TIM-1) at an MOI of 2, 4, or 8. For these transductions, treated cells were lifted with 5 mM EDTA in PBS at 24 h posttransfection/posttransduction and split into two groups. The first group was analyzed for TIM-1 surface expression by flow cytometry, and the second was distributed into separate tissue culture plates for LASV-VSV transduction. For each set of these experiments, the same quantity of LASV-VSV was transduced across all untreated and treated cells.
Zika virus infections. Six-well plates of HEK 293T cells were transfected with 2.5 g of an Axl expression plasmid or an empty vector using Lipofectamine 2000 according to the manufacturer's instructions. The next day, cells were lifted, and 10,000 cells were plated in a 96-well format or held in the 6-well format. Twenty-four hours later, cells from the 6-well plate were lifted and evaluated for Axl surface expression on cells by flow cytometry using a 1:200 dilution of goat anti-Axl polyclonal antibody (R&D Systems). The 96-well plate of transfected cells was infected with Zika virus (Puerto Rico strain) at an MOI of 0.25. After 3 days of infection, cells were placed into TRIzol, and RNA was extracted. One microgram of RNA was reverse transcribed, the cDNA was diluted 1:50, and quantitative real-time PCR (qRT-PCR) was performed using primers (forward primer 5=-AARTACACATACCARAACAAAGTGGT-3= and reverse primer 5=-TCCACTCCCTCTCTGGTCTTG-3=) (78) against the Zika virus genome. The C T (threshold cycle) values were converted to virus copy numbers using a standard curve of genome equivalents.
Axl migration assay. HEK 293T cells expressing an empty vector, Axl, or murine bone marrow stromal antigen 2 (mBST-2) were plated on the apical chamber of 24-well cell culture inserts (Merck Millipore) at a concentration of 10 5 cells/insert in 100 l of serum-free Opti-MEM. Opti-MEM (600 l) containing 10% FBS with or without 0.5 g/ml of Gas6 (R&D Systems) was added to the basal chamber, and cells were allowed to migrate for 24 h at 37°C. Nonmigrated cells were washed off, and migrated cells were fixed, permeabilized, stained, and imaged as previously described (79) . Migrated cells from at least five different 10ϫ fields were counted using ImageJ software and averaged.
Statistics. All studies were performed at least three independent times with two to three replicates in each experiment. Raw data were normalized to control values and are shown as either transduction levels relative to control values or increases in expression or transduction relative to baseline values. Means and standard deviations for all studies were generated and statistical differences were evaluated by two-way analysis of variance (ANOVA). Differences were deemed significant if P values were less than 0.05.
